Site Search
Company Search
Get Quote
The SeriousTraders Newsletter If you are Serious about Trading, become a SeriousTrader!™
SeriousTradersSpotlight Company
Oragenics Inc. (NYSE American: OGEN)
Investment Considerations Oragenics’ lead candidate, ONP-002, addresses a significant unmet medical need in concussion treatment with a stable, non-invasive delivery method that offers substantial market potential. The company’s proprietary intranasal delivery technology opens opportunities for expansion into multiple high-demand sectors, including neurology and infectious diseases. Oragenics’ ability to eliminate cold storage requirements for ONP-002 enhances … Continue reading “Oragenics Inc. (NYSE American: OGEN)”
Latest Press Releases
Filter Releases
| Symbol | Release | Time |
|---|---|---|
| {{ release.qmtopics.qmsymbol[0].symbol }} | {{ release.headline }} | {{ release.datetime | amDateFormat:'hh:mm A'}} |
SeriousTraders is part of the IBN (InvestorBrandNetwork). Other brands within the investor brand network include:
